For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Protiva Biotherapeutics, Inc.

USPTO Granted Patents = 45

CIPO Patents = 25

EPO Patents = 17

Forward Citations = 4,006

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

Ian MacLachlan (38 out of 50 patents)

Lorne Ralph Palmer (18 out of 28 patents)

James Heyes (16 out of 30 patents)

4. Adam Judge (13 out of 21 patents)

5. Lloyd B Jeffs (12 out of 18 patents)

6. Amy C H Lee (7 out of 13 patents)

7. Ed Yaworski (6 out of 11 patents)

8. Edward D Yaworski (5 out of 7 patents)

9. Kieu Lam (5 out of 9 patents)

10. Mark Wood (4 out of 19 patents)

11. Alan Martin (4 out of 10 patents)

12. Cory Giesbrecht (4 out of 6 patents)

13. Marjorie Ann Robbins (4 out of 6 patents)

14. Ellen Grace Ambegia (3 out of 3 patents)

15. Stephen P Reid (2 out of 6 patents)

45 patents: Sort by Forward Citations

1. 9926560 - Lipid encapsulating interfering RNA (2018-03-27),

2. 9878042 - Lipid formulations for delivery of therapeutic agents to solid tumors (2018-01-30),

3. 9765333 - Compositions and methods for silencing marburg virus gene expression (2017-09-19),

4. 9518272 - Non-liposomal systems for nucleic acid delivery (2016-12-13),

5. 9504651 - Lipid compositions for nucleic acid delivery (2016-11-29),

6. 9492386 - Liposomal apparatus and manufacturing methods (2016-11-15),

7. 9428751 - Compositions and methods for silencing apolipoprotein C-III expression (2016-08-30),

8. 9404127 - Non-liposomal systems for nucleic acid delivery (2016-08-02),

9. 9364435 - Lipid formulations for nucleic acid delivery (2016-06-14),

10. 9352042 - Trialkyl cationic lipids and methods of use thereof (2016-05-31),

11. 9222086 - Compositions and methods for silencing genes expressed in cancer (2015-12-29),

12. 9181545 - Lipid encapsulating interfering RNA (2015-11-10),

13. 9126966 - Cationic lipids and methods of use thereof (2015-09-08),

14. 9074208 - Modified siRNA molecules and uses thereof (2015-07-07),

15. 9035039 - Compositions and methods for silencing SMAD4 (2015-05-19),

Protiva Biotherapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapies for the treatment of genetic diseases and cancers. With a mission to improve patient outcomes, Protiva Biotherapeutics leverages its expertise in lipid nanoparticle technology to deliver therapeutic RNA molecules directly into cells. By advancing cutting-edge research and collaborating with leading experts in the field, Protiva Biotherapeutics aims to revolutionize the way genetic diseases and cancers are treated and bring hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

45 Patents

#10 in Burnaby

#296 in Canada

#14,962 in the World

Burnaby, Canada

Protiva Biotherapeutics, Inc.

Forward Citations = 4,006

52 inventors:

Ian MacLachlan (38 out of 50 patents)

Lorne Ralph Palmer (18 out of 28 patents)

James Heyes (16 out of 30 patents)

4. Adam Judge (13 out of 21 patents)

5. Lloyd B Jeffs (12 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…